2019, Number 2
Next >>
Rev Invest Clin 2019; 71 (2)
Clinical and Biomedical Applications of Surface Plasmon Resonance Systems
Meza-Sánchez DE, Maravillas-Montero JL
Language: English
References: 10
Page: 85-90
PDF size: 264.74 Kb.
ABSTRACT
Surface plasmon resonance (SPR)-based biosensors offer superior analytical features such as simplicity, sensitivity, and specificity
when compared to conventional methods in clinical analyses. In addition, they deliver real-time monitoring of label-free
analytes with high-throughput approaches requiring little sample pretreatment that allows the analysis of virtually every clinical
sample type to determine the amount and/or activity of any molecule of interest. Accordingly, SPR emerges as a novel, efficient,
powerful, and relatively low-cost alternative tool for routine clinical analysis, opening also new horizons for developments in
personalized medicine applied to diagnostics or therapeutics’ monitoring.
REFERENCES
Rich RL, Myszka DG. Advances in surface plasmon resonance biosensor analysis. Curr Opin Biotechnol. 2000;11:54-61.
Malmqvist M. BIACORE: an affinity biosensor system for characterization of biomolecular interactions. Biochem Soc Trans. 1999;27:335-40.
Mariani S, Minunni M. Surface plasmon resonance applications in clinical analysis. Anal Bioanal Chem. 2014;406:2303-23.
Wang DS, Fan SK. Microfluidic surface plasmon resonance sensors: from principles to point-of-care applications. Sensors (Basel). 2016;16:E1175.
Yanase Y, Hiragun T, Ishii K, et al. Surface plasmon resonance for cell-based clinical diagnosis. Sensors (Basel). 2014;14:4948-59.
Bergwerff AA, van Knapen F. Surface plasmon resonance biosensors for detection of pathogenic microorganisms: strategies to secure food and environmental safety. J AOAC Int. 2006;89: 826-31.
Wittenberg NJ, Wootla B, Jordan LR, et al. Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseases. Expert Rev Neurother. 2014;14:449-63.
Masson JF. Surface plasmon resonance clinical biosensors for medical diagnostics. ACS Sens. 2017;2:16-30.
Ferhan AR, Jackman JA, Park JH, Cho NJ, Kim DH. Nanoplasmonic sensors for detecting circulating cancer biomarkers. Adv Drug Deliv Rev. 2018;125:48-77.
Gunn GR 3rd, Sealey DC, Jamali F, et al. From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals. Clin Exp Immunol. 2016;184:137-46.
Full text